scholarly journals BLASTOCYSTIS HOMINIS: A MYSTERIOUS AND COMMONLY DISREGARDED PARASITE

Author(s):  
Nataša Tasić ◽  
Tatjana Milenković ◽  
Vera Bujić ◽  
Dragan Zdravković ◽  
Aleksandar Tasić

Blastocystis hominis (B. hominis) is an anaerobic, single-cell protozoan, commonly present in human and animal stool samples. It can be found in healthy people as well and it still has not been elucidated whether it is a commensal organism or a pathogen. Blastocystosis is a disease caused by the protozoan in humans. The prevalence of the parasitosis varies both between the countries, and between certain population groups within individual countries. Due to poor hygienic conditions, common exposure to animals and intake of contaminated water and food, people in the developing countries have got a higher prevalence of blastocystosis, but economically developed countries have not been spared either. The taxonomy of B. hominis is still a matter of debates. For the reasons of genetic diversity, it has been suggested that the name B. hominis should be replaced with „Blastocystis species‟. Seventeen subtypes of the species have been so far identified, and a definitive characterization of Blastocystis spp. is possible at the molecular level only. The parasite is transferred by the fecal-oral route. A variety of hosts have been identified, and animal-to-human and vice versa transfers have been documented. The most common manifestations of the infection with the organism are diarrhea, abdominal pain, nausea, and bloating. This infection has also been associated with the irritable bowel syndrome (IBS), non-specific colitis, chronic inflammatory bowel disease (CIBD), and urticaria. The diagnosis can be made using the methods of conventional microscopy (CVM), phase-contrast and electron microscopy, cultivation, serodiagnosis, and by using molecular methods. The infection caused by the parasite does not always require treatment. In symptomatic patients, the first line medical treatment is metronidazole. Further studies are required to resolve all dilemmas regarding the parasite.

2020 ◽  
Vol 20 (2) ◽  
Author(s):  
Sarah Firdausa ◽  
Yuliasih Yuliasih

Abstrak. Enteropatik artritis adalah bentuk artritis yang terkait dengan penyakit peradangan usus kronis /irritable bowel disease (IBD) dengan manifestasi tersering berupa kolitis ulseratif, dan penyakit Crohn. Ini merupakan salah satu manifestasi klinis dari spondiloartritis seronegatif. Diare dan artritis merupakan dua hal yang sering muncul sebagai gejala klinis pada enteropatik artritis. Salah satu alarm symptom pasien enteropatik artritis adalah buang air besar (BAB) cair dan berdarah. Berikut dilaporkan seorang pasien dengan keluhan BAB berdarah yang disebabkan enteropatik artritis yang mendapat terapi non farmakologis dan farmakologis, pasien mengalami perbaikan secara klinis dan dapat menjalani terapi lanjutan secara optimal melalui poli rheumatologi. Kata kunci: Enteropatik artritis, diare berdarah, colitis Abstrak. Enteropathic arthritis is a form of arthritis which associated with chronic inflammatory bowel disease (IBD). The most common manifestations are ulcerative colitis and Crohn's disease. This is one of the clinical spectrum of seronegative spondylarthritis. Diarrhea and arthritis are two symptoms that often appear as clinical manifestation in enteropathic arthritis. One of the alarm symptoms of enteropathic arthritis patients is haematoschezia. In this article, we reported a patient with bloody diarrhea caused by enteropathic arthritis. He received non-pharmacological and pharmacological therapy, and experienced clinical improvement. He then can undergo optimal further therapy through poly rheumatology. Keywords: arthritis enteropathic, bloody diarrhea, colitis


PLoS ONE ◽  
2021 ◽  
Vol 16 (5) ◽  
pp. e0252428
Author(s):  
Raphael Trefzer ◽  
Orly Elpeleg ◽  
Tatyana Gabrusskaya ◽  
Polina Stepensky ◽  
Hagar Mor-Shaked ◽  
...  

Diaphanous related formins are highly conserved proteins regulated by Rho-GTPases that act as actin nucleation and assembly factors. Here we report the functional characterization of a non-inherited heterozygous FMNL2 p.L136P mutation carried by a patient who presented with severe very early onset inflammatory bowel disease (IBD). We found that the FMNL2 L136P protein displayed subcellular mislocalization and deregulated protein autoinhibition indicating gain-of-function mechanism. Expression of FMNL2 L136P impaired cell spreading as well as filopodia formation. THP-1 macrophages expressing FMNL2 L136P revealed dysregulated podosome formation and a defect in matrix degradation. Our data indicate that the L136P mutation affects cellular actin dynamics in fibroblasts and immune cells such as macrophages.


Sign in / Sign up

Export Citation Format

Share Document